Provider Alert! Issues with EpiPen, Epi-Pen Jrs, and related generic products
Attention: All Providers and Pharmacies Effective Date: April 21, 2020 Call to action: The FDA is alerting stakeholders that EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and authorized generic versions, may potentially have delayed or inappropriate injecting. Reasons for failure include: Device failure from spontaneous activation caused by using sideways force to remove the blue safety release Device failure from inadvertent or spontaneous activation due to a raised blue safety release Difficulty removing the device from carrier tube User error may also delay or prevent the...
